Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 813 results for "merck co"

Johnson & Johnson Vs. Merck For Dividends In Retirement

Do you love dividend paying stocks for your retirement portfolio? Many of us do. But the question is, are you looking for dividend yield, dividend growth or both? Both Dividend Yield And Growth Are Important For Retirement Income In today's ... Seeking Alpha, 2 weeks ago

167 images for merck co

Pharma Letter, 1 day ago
Jutia Group, 2 days ago
Njbiz, 2 weeks ago
Awake Africa, 2 weeks ago
Share Market Updates, 6 days ago
Share Market Updates, 1 week ago
Share Market Updates, 1 week ago
American Banking News - Forex, 6 days ago
Nasdaq, 2 weeks ago
Nasdaq, 2 weeks ago

Merck's Former Chief Medical Officer to Join Flagship Ventures

Merck & Co.'s former chief medical officer, Michael Rosenblatt, will join Flagship Ventures, advising the venture capital firm's biotechnology startups with an eye toward creating successful drugs at a time when insurers crack down on reimbursement.
 Bloomberg2 weeks ago Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer  Healthcare Dive2 weeks ago

BRIEF- Mercks Healthcare invests majority stake in Staywell

July 11 Merck & Co Inc * Merck's Healthcare Services & Solutions invests in majority stake in Staywell * Terms of transaction were not disclosed. Source text for Eikon: Further company coverage: Our top photos from the last 24 ...
 Reuters UK2 weeks ago Merck's Healthcare Services & Solutions Invests in Majority Stake in StayWell  Business Wire2 weeks ago MERCK : Mercks Healthcare Services & Solutions Invests in Majority Stake in StayWell  4 Traders2 weeks ago Merck's Healthcare Services and Solutions Invests in Majority Stake in StayWell  SPi World News2 weeks ago
[x]  

Fitch Affirms Merck's IDR at 'A'; Outlook Stable

CHICAGO--( BUSINESS WIRE )--Fitch Ratings has affirmed Merck & Co., Inc.'s (MRK/Merck) Long-Term Issuer Default Rating at 'A'. The Rating Outlook is Stable. A complete list of rating actions follows at the end of this press release. KEY RATING ...
 Business Wire2 weeks ago
[x]  
Share Market Updates

Merck & Co. (MRK) Receives Hold Rating from Leerink Swann

Leerink Swann restated their hold rating on shares of Merck & Co. (NYSE:MRK) in a report published on Thursday. They currently have a $58.00 price target on the stock. Merck & Co. (NYSE:MRK) opened at 59.65 on Thursday. Merck & Co. has a one year ...
 SleekMoney1 week ago Meeder Asset Management Inc. Has $6,853,000 Position in Merck & Co. (MRK)  SleekMoney1 week ago Optimum Investment Advisors Increases Position in Merck & Co. (MRK)  WKRB News1 week ago Lazard Asset Management LLC Lowers Stake in Merck & Co. (MRK)  SleekMoney1 week ago
[x]  

Merck, Pfizer begin phase III study to evaluate avelumab as first-line treatment for ovarian cancer

Merck KgaA and Pfizer announced the initiation of a phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of avelumab in combination with, and/or as follow-on (maintenance) treatment to, platinum-based chemotherapy in patients ...
 PharmaBiz2 weeks ago Merck & Co. And Pfizer Initiate Phase III Trial To Evaluate Avelumab As First-Line Treatment For Ovarian Cancer  BioSpace3 weeks ago Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer  Yahoo! Singapore3 weeks ago Merck and Pfizer initiate Phase III trial to evaluate Avelumab as first-line treatment for ovarian cancer  World Pharma News2 weeks ago
[x]  
Reuters UK

Pfizer, Merck begin large ovarian cancer trial

Reuters: Pfizer Inc and German drugmaker Merck KGaA last week said they had begun a late-stage trial of their immuno-oncology drug avelumab in combination with standard treatment for ovarian cancer. The 950-patient study will enroll patients with ...
 DailyFT2 weeks ago Pfizer, Germany's Merck begin large ovarian cancer trial  Reuters UK3 weeks ago Pfizer, Germanys Merck begin large ovarian cancer trial  Reuters UK3 weeks ago Pfizer, Germany's Merck begin...  DailyNews724.com2 weeks ago
[x]  
Zacks.com

Merck KGaA/Pfizer Avelumab in JAVELIN Ovarian 100 Study

Merck KGaA MKGAF and its partner Pfizer Inc. PFE announced that they have initiated a phase III study JAVELIN Ovarian 100 on avelumab, in combination with platinum-based chemotherapy, for the treatment of patients with locally advanced or ...
 Zacks.com2 weeks ago Late-stage study commences assessing Merck KGaA and Pfizer's avelumab + chemo in advanced ovarian cancer  Seeking Alpha3 weeks ago
[x]  

Merck CEO Sells 60,000 Company Shares

- By Jennifer Chiou Kenneth Frazier (Insider Trades), CEO, president and chairman of Merck & Co. Inc. (MRK), sold 60,000 company shares at a per share price of $58.00 on July 5. The total transaction was $3.48 million. Merck is a health care ...
 Yahoo! Finance3 weeks ago Merck CEO Sells 6…,……… Company Shares  Guru Focus3 weeks ago
Motley Fool

Better Buy: Celgene Corporation vs. Merck

Celgene Corp. ( NASDAQ:CELG ) and Merck ( NYSE:MRK ) are both top-flight biopharma stocks with significant footprints in the rapidly growing oncology market. But which is the better stock to buy right now? Let's dig deeper to find out. Image ...
 Motley Fool3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less